UP a whopping 20%......off of recent lows (lol)
Still don't know why my low-ball Cdn bid was bypassed ?
Unlikely cash will need to be raised this year (having just raised in November) ... as they progress through the Phase 3B confirmatory Trial...and approach Interim Data release ...on their way to another big installment from their "quasi equity" multi Billion $ MC partner Baxter...who owns 1/2 of the ICU equipment business in the US...and who is planning a kidney/Sepsis focussed spin-off Company later this year or early next.
With a Trial enrolment uptick, and a second Baxter payment, some believe that the next financing will not be needed until well into the future, if ever. Let's see.
glta
MM